Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
(chemotherapy and targeted agents) as well as phase I-III clinical trials are offered at 4 of our 6 off-site locations. The section of gynecologic oncology is among the largest disease site teams within
-
Rights Associate. These activities enhance the global presence and impact of the Press and its authors and contribute to the Press’s income. The position is based on the University of Chicago’s Hyde Park
-
presence and impact of the Press and its authors and make key contributions to the Press’s income. The position is based on the University of Chicago’s Hyde Park campus and location in the Chicago area is
-
models, and faculty engagement. The Director collaborates closely with hospital and departmental leadership to advance service line growth, operational efficiency, and alignment with institutional goals
-
Department BSD OBG - Griffith Lab About the Department This position will be based in the Women’s Brain Health research program led by Dr. Francesca Farina, Assistant Professor in the Department
-
quality, patient safety, staffing models, and provider engagement. They work collaboratively with hospital and departmental leadership to ensure seamless integration of urgent aid services within
-
accelerated our nuclear medicine and radiotracer development capabilities. The position provides access to a robust research ecosystem, including advanced theranostic agents, a dedicated theranostic cyclotron
-
: Textual Prediction of Survival (LLM classification & Attention Modelling) This project develops a model to predict patient survival by analyzing heterogeneous clinical documents. Unlike traditional methods
-
, department, and institute. UChicago’s Regional Advancement team is organized into four regional teams, Central, West, East, and Global. This model is part of a broader institutional commitment, approved by
-
related to genetics, cancer biology, and cellular biology. The role will help oversee projects that utilize mouse models, cellular culture models, CRISPR-based gene editing, and next-generation sequencing